Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Patience David. Officer active across 2 companies, notably Accelerate Diagnostics, Inc. Aggregated, 21 filings have been logged. Split: 0 buy · 4 sells. Total volume traded: €2k. Activity tracked since 13 April 2023. The latest transaction was disclosed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Patience David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
14,650 shares@ US$4.460.023% mcap100.0% of flowCommon StockSEC:0001628280-26-047217:0
65,000 shares0Common StockSEC:0001970009-25-000004:0
200,000 shares0Common StockSEC:0001826667-25-000121:0
20,000 shares0Common StockSEC:0001104659-25-031298:0
1,500 shares0Common StockSEC:0001104659-25-018521:0
37,468 shares0Common StockSEC:0001104659-24-045899:0
1,000 shares0Common StockSEC:0001104659-24-028325:0
350 shares@ US$0.9614.2% of flowCommon StockSEC:0001104659-24-028325:1
16,666 sharesCommon StockSEC:0001104659-24-006671:0
331 shares0Common StockSEC:0001104659-23-126067:0
331 shares0Common StockSEC:0001104659-23-118221:0
97 shares@ US$5.5723.1% of flowCommon StockSEC:0001104659-23-118221:1
331 shares0Common StockSEC:0001628280-23-034442:0
331 shares0Common StockSEC:0001104659-23-100789:0
331 shares0Common StockSEC:0001628280-23-029596:0
95 shares@ US$6.8027.1% of flowCommon StockSEC:0001628280-23-029596:1
330 shares0Common StockSEC:0001628280-23-025009:0
3,309 shares0Common StockSEC:0001628280-23-022178:0
3,309 shares0Common StockSEC:0001628280-23-018496:0
1,222 shares@ US$0.6935.5% of flowCommon StockSEC:0001628280-23-018496:1
3,309 shares0Common StockSEC:0001628280-23-011840:0
About Patience David
Patience David has filed 18 forms in total. Across the 18 recent sampled filings between 2023-04-17 and 2025-04-02, sales total EUR 2183 and the stated transaction nature is option exercise. She is listed as Chief Financial Officer at Accelerate Diagnostics, Inc.